Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Clinical and Experimental Rheumatology|April 22, 2015
Long-term repopulation of peripheral B-cell subsets after single and repeated rituximab infusions in patients with rheumatoid arthritisPetra Roll, Zafar Mahmood, Khalid Muhammad, et al.
European Journal of Haematology|February 14, 2015
Effect of ATG-F on B-cell reconstitution after hematopoietic stem cell transplantationPetra Roll, Khalid Muhammad, Gernot Stuhler, et al.
The Journal of Rheumatology|April 17, 2012
Rituximab therapy leads to reduced imprints of receptor revision in immunoglobulin κ and λ light chainsArumugam Palanichamy, Khalid Muhammad, Petra Roll, et al.
Cornea|September 26, 2014
Correlation between tear film osmolarity, dry eye disease, and rheumatoid arthritisMarc Schargus, Franziska Wolf, Hans-Peter Tony, et al.
Frontiers in Immunology|May 17, 2021
Induction of IL-9 in Peripheral Lymphocytes of Rheumatoid Arthritis Patients and Healthy Donors by Th17-Inducing Cytokine ConditionsJana Heim, Giovanni Almanzar, Marc Schmalzing, et al.
Blood|March 8, 2003
Gammadelta T cells for immune therapy of patients with lymphoid malignanciesMartin Wilhelm, Volker Kunzmann, Susanne Eckstein, et al.
RMD Open|October 25, 2023
Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT registerYvette Meissner, Martin Schäfer, Katinka Albrecht, et al.
Arthritis Research & Therapy|August 19, 2022
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapyMichael Gernert, Marc Schmalzing, Hans-Peter Tony, et al.
Annals of the Rheumatic Diseases|May 10, 2011
Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cellsKhalid Muhammad, Petra Roll, Thomas Seibold, et al.
Arthritis and Rheumatism|February 10, 2011
In vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartmentPetra Roll, Khalid Muhammad, Mathias Schumann, et al.
Pageof 11